BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/20/2024 9:15:32 AM | Browse: 413 | Download: 1480
Publication Name World Journal of Gastroenterology
Manuscript ID 91660
Country Hungary
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Prospective Study
Article Title Non-pancreatic hyperlipasemia: A puzzling clinical entity
Manuscript Source Invited Manuscript
All Author List Krisztina Eszter Feher, David Tornai, Zsuzsanna Vitalis, Laszlo Davida, Nora Sipeki and Maria Papp
ORCID
Author(s) ORCID Number
Krisztina Eszter Feher http://orcid.org/0009-0008-0183-6535
David Tornai http://orcid.org/0000-0002-1335-5498
Zsuzsanna Vitalis http://orcid.org/0000-0001-8198-5312
Laszlo Davida http://orcid.org/0000-0001-6575-002X
Nora Sipeki http://orcid.org/0000-0002-6806-2991
Maria Papp http://orcid.org/0000-0003-3662-4010
Funding Agency and Grant Number
Funding Agency Grant Number
the Economic Development and Innovation Operative Program Grant GINOP 2.3.2- 15-2016-00048 “StayAlive”
Human Resources Development Operational Program Grant of the National Research Development and Innovation Office EFOP-3.6.2-16-2017-00006
Corresponding Author Maria Papp, DSc, FEBG, MD, PhD, Professor, Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei Blv 98, Debrecen H-4032, Hajdu-Bihar, Hungary. papp.maria@med.unideb.hu
Key Words Non-pancreatic hyperlipasemia; Acute pancreatitis; Glycoprotein 2; Acute kidney injury; Sepsis; Mortality
Core Tip Non-pancreatic hyperlipasemia is a common and puzzling clinical entity in the differential diagnosis of acute pancreatitis (AP). The etiology of NPHL varies; however, sepsis and acute kidney injury (AKI) are the most prevalent causes. NPHL was associated with a high in-hospital mortality rate (22.4%). A readily available laboratory marker, the neutrophil-to-lymphocyte ratio, with a cut-off value > 10.37, has been the best independent laboratory predictor of mortality, with a nearly 4-fold increased risk. In the laboratory diagnosis of AP, the presence of complications, especially sepsis and AKI, warrants clinical attention, as it has a significant negative impact on the diagnostic accuracy of lipase.
Publish Date 2024-05-20 09:15
Citation

Feher KE, Tornai D, Vitalis Z, Davida L, Sipeki N, Papp M. Non-pancreatic hyperlipasemia: A puzzling clinical entity. World J Gastroenterol 2024; 30(19): 2538-2552

URL https://www.wjgnet.com/1007-9327/full/v30/i19/2538.htm
DOI https://dx.doi.org/10.3748/wjg.v30.i19.2538
Full Article (PDF) WJG-30-2538-with-cover.pdf